Categorie -wet- en regelgeving

bv CGR, GDPR

AstraZeneca's Farxiga gets US FDA approval to reduce risk of CV death

wet- en regelgeving

AstraZeneca’s Farxiga gets US FDA approval to reduce risk of CV death and hospitalisation for heart failure to a broader range of patients

10 mei 2023

Pharma Biz

US FDA grants 510(k) clearance and CE Mark approval for Norlase's ECHO Green Pattern Laser

wet- en regelgeving

US FDA grants 510(k) clearance and CE Mark approval for Norlase’s ECHO Green Pattern Laser

8 mei 2023

Pharma Biz

Aptar Pharma & RDD Online to co-organize RDD Europe 2023 at Antibes (Nice)

wet- en regelgeving

Aptar Pharma & RDD Online to co-organize RDD Europe 2023 at Antibes (Nice), France from May 2 to 5, 2023

7 mei 2023

Pharma Biz

FDA Approves Lumryz for Narcolepsy

wet- en regelgeving

FDA Approves Lumryz for Narcolepsy

5 mei 2023

Drugs.com: Drug Information Online

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

wet- en regelgeving

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

4 mei 2023

National Library of Medicine: MedlinePlus

Five things for pharma marketers to know:

wet- en regelgeving

Five things for pharma marketers to know: Tuesday, May 2, 2023

3 mei 2023

MMM - Medical Marketing and Media

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer